Source: Annual Congress 2007 - Clinical year in review
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
P. Levy (Grenoble, France). OSAS as a link between diseases of different systems. Annual Congress 2007 - Clinical year in review

Member's Comments

No comment yet.

Related content which might interest you: Metabolic consequences in obstructive sleep apnoea Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts Year: 2006 Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients Source: Eur Respir J 2009; 34: 694 Year: 2009 Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Determinant factors of serum leptin levels in patients with obstructive sleep apnea Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Sleep-disordered breathing and hormones Source: Eur Respir J 2003; 22: 161-172 Year: 2003 Obstructive sleep apnea syndrome in obese patients: adiponectin levels Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 CPAP and measures of cardiovascular risk in males with OSAS Source: Eur Respir J 2008; 32: 1488-1496 Year: 2008 Outcomes of OSA and indications for different therapies Source: Eur Respir Mon 2010; 50: 225-243 Year: 2010 Progression of snoring and obstructive sleep apnoea: the role of increasing weight and time Source: Eur Respir J 2009; 33: 338-345 Year: 2009 Relationship between obstructive sleep apnea syndrome (OSAS) and obesity, cholesterol disorders, blood pressure, and anatomical alterations Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006 Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Treatment options for central sleep apnea (including auto-CPAP) Source: Annual Congress 2005 - Central sleep apnoea Year: 2005 Multifrequency body composition, anthropometric indices and hydration status in severe obstructive sleep apnea patients. The role of trunk adiposity. Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea Year: 2020 Cardiovascular and metabolic effects of CPAP in obese males with OSA Source: Eur Respir J 2007; 29: 720-727 Year: 2007 Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2003; 22: 251-257 Year: 2003 Sleep apnoea and systemic hypertension Source: Eur Respir Mon 2010; 50: 150-173 Year: 2010 Airway‘s leptin, body mass index and obstructive sleep apnea: is there any correlation? Source: Eur Respir J 2006; 28: Suppl. 50, 412s Year: 2006 Proportional positive airway pressure: a new concept to treat obstructive sleep apnoea Source: Eur Respir J 2001; 17: 467-473 Year: 2001 Continuous positive airway pressure treatment in patients with OSA Source: Eur Respir Mon 2010; 50: 244-266 Year: 2010